STEPHANIE FLYGARE: Open Payments
NPI 1174662357 · SPRINGFIELD, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$434 in 15 payments from 8 companies in 2025. Trend: 2023 $458 · 2024 $292 · 2025 $434
Food & beverage: $434
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 6 | $183 |
| Madrigal Pharmaceuticals | 1 | $88 |
| ABBVIE INC. | 2 | $58 |
| Exact Sciences Corporation | 2 | $34 |
| Dexcom, Inc. | 1 | $22 |
| Novo Nordisk Inc | 1 | $21 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $14 |
| Lilly USA, LLC | 1 | $14 |
Products named: REXULTI, REZDIFFRA, VRAYLAR, Cologuard Collection Kit, Dexcom G6 Transmitter, Wegovy, CAPLYTA, KISUNLA.
Industry payments across MO — which companies pay providers there.
